Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

Ultrasound Screening Effective for Second Trimester Markers for Down’s Syndrome

By Medimaging International staff writers
Posted on 11 Feb 2013
Print article
A new analysis has found that some second trimester markers for Down’s syndrome that are detected by ultrasound are more important than other markers for the disease. Insights from this research should help adjust pregnant women’s risks for having a child with the disorder.

Down’s syndrome screening is offered to all pregnant women, starting with a background risk based on their age. Specific characteristics identified during a second trimester ultrasound scanning are possible markers for Down’s syndrome, and they include increased thickness of the back of the neck, dilated brain ventricles, absent or small nose bone, an abnormal artery to the upper extremities, bright spots in the heart, “bright” bowels, mild kidney swelling, and shortening of an arm bone or thigh bone.

To determine how these markers affect risk, Kypros Nicolaides, MD, from the Harris Birthright Research Center for Fetal Medicine at King’s College London (UK), and his colleagues analyzed all published data that reported findings on second trimester markers for Down’s syndrome between 1995 and 2012. The findings were published early online January 24, 2013, in the journal Ultrasound in Obstetrics & Gynecology.

The researchers identified 48 studies, and they discovered that most single markers have only a small effect on modifying the risks for Down’s syndrome. This finding could have important clinical implications because currently in the United States, when a marker such as a thighbone or short arm is identified, women are told that they are at high risk of having a child with Down’s syndrome. However, Dr. Nicolaides and his coworkers discovered that a few markers do carry increased risks. Increased thickness of the back of the neck, dilated brain ventricles, and an abnormal artery to the upper extremities increase the risk by three- to four-fold, and an absent or small nose bone increases the risk by six- to seven-fold.

“The detection of any one of the findings during the scan should prompt the sonographer to look for all other markers or abnormalities,” said Prof. Nicolaides. He added that the study also revealed that if a detailed second trimester ultrasound scan shows the absence of all major markers, the risk of having an infant affected by Down’s syndrome is decreased by more than seven-fold.

The study findings implied that the comparative significance of ultrasound markers is very different from what has been earlier believed. Prof. Nicolaides noted that these findings will be incorporated in obstetric ultrasound scan software that adjusts women’s risks for having a child with Down’s syndrome.

Related Links:
Harris Birthright Research Centre for Fetal Medicine at King’s College London



Print article
Radcal

Channels

Nuclear medicine

view channel
Image: The newly approved PET imaging agent Fluciclovine (18F) anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid (FACBC) is a synthetic amino acid (Photo courtesy of Blue Earth Diagnostics).

New PET Imaging Agent for Recurrent Prostate Cancer Approved by US FDA

The US Food and Drug Administration (FDA) has approved the first PET imaging molecular imaging agent for use in patients who have suspected recurrent prostate cancer. The agent is indicated for use... Read more

Imaging IT

view channel
Image: New workflow options are available for the Compass Routing and Workflow Manager (Photo courtesy of Laurel Bridge Software).

Enterprise Workflow Solutions Provider Announces New Options

A software company that provides enterprise medical imaging workflow solutions has announced that it has added new workflow features for the company’s routing and workflow management system.... Read more

Industry News

view channel

Nuclear Medicine Market Exhibits Slow Growth

The slow growth of the global nuclear medicine market is driven by lower revenues from technetium-99m-related products and unfavorable USD exchange rates against major currencies. These are the latest findings of Medraysintell (Louvain-la-Neuve, Belgium), a provider of strategic intelligence for radiation healthcare.... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.